Evidence indicates that the levels of lipid such as plasma TC, TG, apo B, apo A1, and HDL-C can be used to monitor disease progression and risk factors; however, lipid regulation may also represent a future treatment target for psychiatric disorders related to PD, such as anxiety disorders and cognitive disorders. Here, APOB is linked to Parkinson disease.